Atara Biotherapeutics (ATRA) just unveiled an announcement.
Eric Dobmeier, a board member of Atara Biotherapeutics, Inc., has decided not to seek re-election at the forthcoming 2024 Annual Meeting, though he will complete his current term. His departure is not due to any conflict with the company’s management or board regarding its operations, policies, or practices.
For an in-depth examination of ATRA stock, go to TipRanks’ Stock Analysis page.
